rs200087210

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001372044.2(SHANK3):​c.4184T>G​(p.Val1395Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000782 in 1,558,972 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/15 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. V1395V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00070 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00079 ( 0 hom. )

Consequence

SHANK3
NM_001372044.2 missense

Scores

1
13

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.353

Publications

0 publications found
Variant links:
Genes affected
SHANK3 (HGNC:14294): (SH3 and multiple ankyrin repeat domains 3) This gene is a member of the Shank gene family. Shank proteins are multidomain scaffold proteins of the postsynaptic density that connect neurotransmitter receptors, ion channels, and other membrane proteins to the actin cytoskeleton and G-protein-coupled signaling pathways. Shank proteins also play a role in synapse formation and dendritic spine maturation. Mutations in this gene are a cause of autism spectrum disorder (ASD), which is characterized by impairments in social interaction and communication, and restricted behavioral patterns and interests. Mutations in this gene also cause schizophrenia type 15, and are a major causative factor in the neurological symptoms of 22q13.3 deletion syndrome, which is also known as Phelan-McDermid syndrome. Additional isoforms have been described for this gene but they have not yet been experimentally verified. [provided by RefSeq, Mar 2012]
SHANK3 Gene-Disease associations (from GenCC):
  • Phelan-McDermid syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics, Laboratory for Molecular Medicine
  • schizophrenia 15
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.014323235).
BP6
Variant 22-50721831-T-G is Benign according to our data. Variant chr22-50721831-T-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 588226.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000697 (106/152182) while in subpopulation AMR AF = 0.00131 (20/15304). AF 95% confidence interval is 0.000865. There are 0 homozygotes in GnomAd4. There are 40 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 106 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001372044.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SHANK3
NM_001372044.2
MANE Select
c.4184T>Gp.Val1395Gly
missense
Exon 24 of 25NP_001358973.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SHANK3
ENST00000692848.2
c.4181T>Gp.Val1394Gly
missense
Exon 22 of 23ENSP00000510794.2A0A8I5KZC4
SHANK3
ENST00000262795.8
TSL:5
c.3599T>Gp.Val1200Gly
missense
Exon 20 of 21ENSP00000489147.3A0A0U1RQS4
SHANK3
ENST00000664402.3
c.2141T>Gp.Val714Gly
missense
Exon 5 of 6ENSP00000499475.2A0A590UJL3

Frequencies

GnomAD3 genomes
AF:
0.000697
AC:
106
AN:
152064
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000266
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000189
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00104
Gnomad OTH
AF:
0.000959
GnomAD2 exomes
AF:
0.000564
AC:
91
AN:
161302
AF XY:
0.000507
show subpopulations
Gnomad AFR exome
AF:
0.000126
Gnomad AMR exome
AF:
0.000745
Gnomad ASJ exome
AF:
0.000117
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000628
Gnomad NFE exome
AF:
0.000983
Gnomad OTH exome
AF:
0.00133
GnomAD4 exome
AF:
0.000791
AC:
1113
AN:
1406790
Hom.:
0
Cov.:
34
AF XY:
0.000783
AC XY:
544
AN XY:
694780
show subpopulations
African (AFR)
AF:
0.000125
AC:
4
AN:
31896
American (AMR)
AF:
0.000873
AC:
32
AN:
36656
Ashkenazi Jewish (ASJ)
AF:
0.0000396
AC:
1
AN:
25224
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36268
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79942
European-Finnish (FIN)
AF:
0.000185
AC:
9
AN:
48584
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5710
European-Non Finnish (NFE)
AF:
0.000955
AC:
1035
AN:
1084154
Other (OTH)
AF:
0.000548
AC:
32
AN:
58356
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
84
168
253
337
421
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000697
AC:
106
AN:
152182
Hom.:
0
Cov.:
33
AF XY:
0.000538
AC XY:
40
AN XY:
74408
show subpopulations
African (AFR)
AF:
0.000265
AC:
11
AN:
41542
American (AMR)
AF:
0.00131
AC:
20
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5166
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
0.000189
AC:
2
AN:
10610
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00104
AC:
71
AN:
67958
Other (OTH)
AF:
0.000949
AC:
2
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.514
Heterozygous variant carriers
0
6
12
17
23
29
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000427
Hom.:
0
Bravo
AF:
0.000688
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000249
AC:
2
ExAC
AF:
0.000376
AC:
43

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
1
Inborn genetic diseases (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.072
BayesDel_noAF
Benign
-0.81
CADD
Benign
16
DANN
Benign
0.93
DEOGEN2
Benign
0.029
T
Eigen
Benign
-0.77
Eigen_PC
Benign
-0.61
FATHMM_MKL
Benign
0.25
N
LIST_S2
Benign
0.37
T
M_CAP
Benign
0.0053
T
MetaRNN
Benign
0.014
T
MetaSVM
Benign
-0.97
T
PhyloP100
0.35
PrimateAI
Uncertain
0.57
T
REVEL
Benign
0.10
Sift4G
Benign
0.38
T
Vest4
0.12
GERP RS
1.2
gMVP
0.44
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200087210; hg19: chr22-51160259; API